Stephanie Reyburn
Family Medicine · Quincy, ILNPI 1134140247
Payments from drug & device makers
Across 450 payments — averaging $12.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- Novo Nordisk$796
- AbbVie$595
- AstraZeneca$584
- Lilly USA, LLC$540
- Pfizer$350
- plus $1K from 24 others
What the payments were for
- Food & beverage$5,45899%
- Education$90%
- Other$240%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 105 | $1,289 |
| Novo Nordisk | 92 | $796 |
| AbbVie | 54 | $595 |
| AstraZeneca | 34 | $584 |
| Lilly USA, LLC | 43 | $540 |
| Pfizer | 32 | $350 |
| Boehringer Ingelheim | 13 | $180 |
| Bayer | 10 | $169 |
| Astellas Pharma US Inc | 10 | $158 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $138 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $69 |
| Johnson & Johnson | 5 | $68 |
| Phathom Pharmaceuticals, Inc. | 4 | $61 |
| Axsome Therapeutics, Inc. | 4 | $60 |
| Sumitomo Pharma America, Inc. | 4 | $60 |
| Novartis | 4 | $50 |
| Currax Pharmaceuticals LLC | 3 | $41 |
| Sanofi Pasteur Inc. | 2 | $32 |
| GSK | 2 | $31 |
| Eisai Inc. | 2 | $30 |
| Supernus Pharmaceuticals, Inc. | 2 | $30 |
| Arbor Pharmaceuticals, Inc. | 2 | $28 |
| Teva Pharmaceuticals USA, Inc. | 2 | $26 |
| Welch Allyn | 2 | $24 |
| Corcept Therapeutics | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $13 |
| Mylan Specialty L.p. | 1 | $12 |
| Boston Scientific | 1 | $12 |
How this compares
$5,492 in reported general payments places this provider in the 90th percentile of 4,116 family medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 56 | $57,784 |
| EliquisApixaban | 104 | $38,931 |
| JardianceEmpagliflozin | 39 | $28,371 |
| MounjaroTirzepatide | 28 | $24,898 |
| TrulicityDulaglutide | 24 | $22,961 |
| KerendiaFinerenone | 28 | $19,390 |
| Repatha SureclickEvolocumab | 25 | $18,605 |
| Tresiba Flextouch U-200Insulin Degludec | 16 | $12,526 |
| FarxigaDapagliflozin Propanediol | 19 | $12,218 |
| Xtampza ErOxycodone Myristate | 11 | $11,705 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 16 | $10,454 |
| MyrbetriqMirabegron | 21 | $8,898 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 14 | $7,151 |
| PremarinEstrogens, Conjugated | 15 | $3,568 |
| Celecoxib | 79 | $3,444 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $796 | $57,78456 claims |
| Lilly USA, LLCMounjaro, Trulicity | $540 | $47,85952 claims |
| PfizerEliquis, Premarin | $350 | $42,499119 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $180 | $35,52253 claims |
| BayerKerendia | $169 | $19,39028 claims |
| AstraZenecaFarxiga | $584 | $12,21819 claims |
| GSKTrelegy Ellipta | $31 | $10,45416 claims |
| Astellas Pharma US IncMyrbetriq | $158 | $8,89821 claims |
| AbbVieSynthroid | $595 | $1,08617 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Quincy
- Divya BatraQuincy$444K
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.